双功能结构域重组FN多肽表达质粒的构建及其表达产物的功能

构建了纤维结合素（ＦＮ）的双功能结构域重组多肽的两个表达质粒,在大肠杆菌中表达了两个重组多肽：ＣＨ５０（ＦＮ的Ｐｒｏ１２３９Ｓｅｒ１５１５经Ｍｅｔ和Ａｌａ１６９０Ｔｈｒ１９６０相连）和ＣＨ５６（ＦＮ的Ｐｒｏ１２３９Ｔｈｒ１９６０）。两个多肽都具有结合肝素的功能,可通过肝素琼脂糖亲和层析得到纯品,所得纯品亦都具有结合细胞的功能。ＣＨ５０和ＣＨ５６的制备为进一步研究其抑制肿瘤转移的作用奠定了基础     

三结构域重组FN多肽表达质粒的构建及其表达产物性质的初步鉴定

为探讨三结构域重组迁连蛋白（ＦＮ）在肿瘤治疗中的作用,构建了两个三结构域重组ＦＮ表达质粒ｐＦ９４－６２和ｐＦ９４－８２,它们分别编码两个重组多肽：ＣＨ６２（ＦＮＰｒｏ１２３９－Ｓｅｒ１５１５经Ｍｅｔ、Ａｌａ １６９０－Ｖａｌ２０４９相连）和ＣＨ８２（从ＣＨ６２中删除了ＨｅｒｐⅡＣ端和ＣｅｌｌⅡ结构域Ｎ端的Ｐｒｏ１９５３－Ｇｌｕ１９７８）。含表达质粒ｐＦ９４－８２的工程菌经３７℃培养,ＣＨ８２得到表     

人神经生长抑制因子β结构域的高效表达及性质研究

神经生长抑制因子（ Ｇ Ｉ Ｆ）是一种特异存在于哺乳动物脑中的金属硫蛋白（ｍ ｅｔａｌｌｏｔｈｉｏｎｅｉｎ, Ｍ Ｔ）类似物,又称 Ｍ Ｔ Ⅲ．它与 Ｍ Ｔ 有相同的结合 Ｚｎ（Ⅱ）, Ｃｄ（Ⅱ）, Ｃｕ（Ⅰ）等金属的能力,但与 Ｍ Ｔ 不同的是它能够抑制神经细胞的生长,并发现在患 Ａｌｚｈｅｉｍ ｅｒ ｄｉｓｅａｓｅ（ Ａ Ｄ 症）病人的大脑中 Ｇ Ｉ Ｆ蛋白量和ｍ Ｒ Ｎ Ａ 的量均显著下降,研究证明 Ｇ Ｉ Ｆ对神经细胞的抑制活性主要存在于其 β结构域中．为进一步研究 β结构域结构和功能的关系,将 β结构域的 ｃ Ｄ Ｎ Ａ 克隆入融合表达载体ｐ Ｇ Ｅ Ｘ ４ Ｔ １ 中, Ｉ Ｐ Ｔ Ｇ 诱导并高效表达了 β结构域蛋白,通过氨基酸组成和质谱的测定,证明得到了目的蛋白．利用金属重组的方法,分别得到了结合 Ｃｄ 和 Ｚｎ 的 Ｇ Ｉ Ｆ 的 β结构域,并测定了其巯基和金属含量对蛋白量的比值,证明所得 Ｇ Ｉ Ｆ β与 Ｍ Ｔ β在结合金属能力上十分相似．用紫外光谱学的研究表明, Ｃｄ Ｍ Ｔ 的 β结构域在２５０ ｎｍ 处比 Ｃｄ Ｇ Ｉ Ｆ 的 β结构域有一明显肩峰,从而表明二者的金属—巯基结合簇的结构有明显不同,而这种结构上的差异有可能导致二者在功能上的不同．     

乙型肝炎、肝硬变和肝癌中HBxAg的表达及其在肝癌发生中的作用

对３７９例良、恶性肝组织进行的免疫组织化学研究显示,３３％的慢性迁延性肝炎（６／１８）、７６％的慢性活动性肝炎（２６／３４）、９２％的肝硬变（５７／６２）和９７％的肝细胞性肝癌（ＨＣＣ）（５８／６０）中有ＨＢｘＡｇ表达,阳性率高于ＨＢｓＡｇ或ＨＢｃＡｇ。癌周肝中的ＨＢｘＡｇ阳性率显著高于非癌周肝。与其它２种ＨＢＶ抗原不同,ＨＢｘＡｇ表达在细胞类型上有较明显的选择性,在肝小多角细胞（ＳＰＬＣ）、小细胞性不典型增生（ＳＣＤ）及ＨＣＣ中较强。与ＩＧＦⅡ、ｃ－ｅｒｂＢ－２、ｃ－ｍｙｃ和ＥＧＦ－Ｒ表达进行的对照研究表明ＨＢｘＡｇ与ＩＧＦⅡ和ｃ－ｅｒｂＢ－２这２种ＨＣＣ发生相关基因的表达关系密切。ＰＣＮＡ染色结果显示ＨＢｘＡｇ阳性组织的细胞增殖活性显著高于ＨＢｘＡｇ阴性组织。我们的结果还表明ＨＢｘＡｇ表达与肝细胞不典型增生的发生和进展有关、提出ＨＢＶＸ基因可能通过其表达产物（ＨＢｘＡｇ）首先激活ＩＧＦⅡ、ｃ－ｅｒｂＢ－２基因,继而引起显著的ＳＰＬＣ增生和ＳＣＤ而参与ＨＣＣ发生的．     

hEGF和hTGF—αN结构域与C结构域的功能差异

用ＰＣＲ的方法将人表皮生长因子和人转化生长因子－α（ｈＴＧＦ－α）的Ｎ结构域和Ｃ结构域互换,构造了两个嵌合分子Ｅ－ＴＧＦ（ＥＧＦ１－３２－ＴＧＦ－α３４－５０）和Ｔ－ＥＧＦ（ＴＧＦ－α１－３３－ＥＧＦ３３－５３）。野生型和嵌合分子基因在大肠杆菌ｐｈｏＡ系统表达并纯化定量。各重组体的受体竞争结合活性大小为ｈＥＧＦ〉ｈＴＧＦ－α和Ｅ－ＴＧＦ〉Ｔ０－ＥＧＦ,它们的促细胞生长活性的大小为ｈＴＧＦ－α和Ｅ－     

高及低转移潜能小鼠肝癌细胞株糖蛋白凝集素结合特征的研究

为探讨肿瘤转移与细胞表面的糖结构的关系,对小鼠肝癌细胞的高、低淋巴道转移株Ｈｃａ－Ｆ和Ｈｃａ－Ｐ进行了蛋白质电泳及经蛋白质印迹术后的５种凝集素（ＣｏｎＡ、ＷＧＡ、ＵＥＡ、ＳＢＡ、ＰＮＡ）结合糖蛋白谱的对比分析．结果表明：高、低转移两株细胞的ＳＤＳ－ＰＡＧＥ谱基本相同;ＣｏｎＡ特异结合糖蛋白共有５种（～７２,８０～９０,～１０４,～１５０,～２００ｋＤ）;其中较明显的差异为～７２ｋＤＣｏｎＡ特异结合糖蛋白,它在Ｈｃａ－Ｐ细胞的表达明显高于Ｈｃａ－Ｆ细胞．ＷＧＡ特异结合糖蛋白１种（～１５０ｋＤ）,在Ｈｃａ－Ｐ细胞的表达略高于Ｈｃａ－Ｆ细胞．此外,实验发现两种性质未明的蛋白质（～７９,～１３０ｋＤ）,后者在Ｈｃａ－Ｐ细胞的含量明显高于Ｈｃａ－Ｐ细胞．结果提示Ｈｃａ－Ｆ和Ｈｃａ－Ｐ细胞不同的转移表型可能与其糖蛋白的表达有一定的关联．     

用pKKH质粒在大肠杆菌中表达HuIFN－β

应用ＤＮＡ重组技术,将ＨｕＩＦＮ－β基因插入到质粒ｐＫＫＨ的ｔａｃ启动子下游,转化大肠杆菌ＪＭ１０１和ＪＭ１０３,经ＩＰＴＧ诱导,表达ＨｕＩＦＮ－β,收集并裂解细菌,用Ｗｉｓｈ－ＶＳＶ系统细胞病变抑制法检测生物学活性为２．１８×１０８－８．７×１０８ＩＵ／Ｌ菌液。经初步纯化ＳＤＳ－ＰＡＧＥ电泳可见分子量为２０ＫＤ较纯的表达带。     

重组人MCAF／GM－CSF融合蛋白表达及其生物学活性研究

利用ＰＣＲ技术和ＤＮＡ体外重组方法,把作为导向效应细胞到靶部位的单核细胞趋化激活因子（ＭＣＡＦ）和粒细胞巨噬细胞集落刺激因子（ＧＭ－ＣＳＦ）进行基因融合,置于ｐＢＶ２２０载体的λＰＲＰＬ串联启动子下游,构建了ＳＤ序列与ＡＴＧ之间含有不同核苷酸组成的重组质粒ｐＭＧ０１、ｐＭＧ０２和ｐＭＧ０３。ｐＭＧ０１、ｐＭＧ０２和ｐＭＧ０３的翻译起始区都不存在稳定的二级结构,但ＤＨ５α（ｐＭＧ０２、ＤＨ５α（ｐＭＧ０３）的表达水平远远高于ＤＨ５α（ｐＭＧ０１）,ＤＨ５α（ＰＭＧ０１）几乎没有表达。表达产物经Ｗｅｓｔｅｒｎｂｌｏｔ检测表明,它能分别与ＭＣＡＦ和ＧＭ－ＣＳＦ抗体发生特异反应。生物学活性测定表明,表达产物具有明显的单核细胞趋化活性和维持ｈＧＭ－ＣＳＦ依赖的ＴＦ１细胞生长的特性,说明ＭＣＡＦ和ＧＭ－ＣＳＦ的生物学功能是相容的．     

逆转录病毒介导CD基因在人结肠癌细胞中表达

构建了含有大肠杆菌胞嘧啶脱氨酶基因（ＥＣ－ＣＤ）的重组逆转录病毒载体ＬＣＤＤＳＮ。经ＰＡ３１７细胞包装后,感染人结肠癌细胞株ＬｏＶｏ。Ｇ４１８筛选得一的稳定表达ＥＣ－ＣＤ基因的细胞克隆ＬｏＶｏ／ＬＣＤＳＮ。ＬｏＶｏ／ＬＣＤＳＮ鹜型ＬｏＶｏ相比,生长曲线无明显差异,细胞形态亦无改变。ＬｏＶｏ／ＬＣＤＳＮ都对５－ＦＵ很敏感（ＩＣ５０约为０．５μｍｏｌ／Ｌ）。表达ＣＤ基因使细胞对基本无毒性的原药５－ＦＣ     

血管内皮细胞生长因子受体Flt—1胞外区基因的克隆及其在中国仓？…

朋原代培养的人脐静脉血管内皮细胞（ＨＵＶＥＣ）提取细胞总ＲＮＡ,采用逆转录ＰＣＲ（ＲＴ－ＰＣＲ）方法得到ＶＥＧＦ受体Ｆｌｔ－１胞外区前３个ＩｇＧ样区域ｃＤＮＡ片段（Ｆｌｔ－１ｎ３）。将获得的受体基因克隆到真核表达载体ｐｃＤ－ＮＡ３．１中,得到重组质粒ｐｃＤＮＡ３．１／Ｆｌｔ－１ｎ３,通过南体转染方法将其转入中国仓鼠卵巢细胞（ＣＨＯ）,用Ｇ４１８筛选得到稳定表达目的蛋白的细胞砍隆。经固相结合实验筛选     

纤维连接蛋白细胞结合区功能多肽在杆状病毒表达系统中的表达与纯化

目的：利用Bac-to-Bac杆状病毒表达系统表达纤维连接蛋白（FN）细胞结合区功能多肽（CBD）,并对其进行纯化和鉴定。方法：经PCR获得人血浆FN-CBD基因,酶切后定向克隆到T载体上,经测序正确后插入pFastBacHTB载体,转化大肠杆菌DH10Bac感受态细胞;用抗生素平板筛选重组杆粒,脂质体介导重组杆粒转染sf9昆虫细胞并进行蛋白表达;经Ni-NTA层析柱对重组多肽进行纯化,对纯化的多肽行SDS-PAGE和Western-blot分析。结果：得到融合6个组氨酸残基的FN-CBD,SDS-PAGE显示其相对分子质量约为36000,Western-blot表明该多肽能与FN的多克隆抗体结合。结论：利用Bac-to-Bac杆状病毒表达系统能成功表达出人血浆FN-CBD,且表达产物具有良好的免疫原性,为后续结构、功能研究奠定了基础。     

High-level expression of a recombinant fragment of human fibronectin containing the Cell I–Hep II–IIICS71 domain in Escherichia coli as a soluble protein

Fibronectin (FN) is a major matrix protein that is involved in multiple processes. Its Cell I–Hep II domain is potentially useful in tumor therapy. Here, a recombinant fragment of FN with the Cell I–Hep II-IIICS71 domain, CH/71, was expressed in Escherichia coli. The CH/71 fusion protein consists of Cell I–Hep II domain and 19th to 89th amino acids of IIICS domain of FN. The expression level of CH/71 in E. coli was very high after induction with IPTG. Furthermore, CH/71 protein was largely found in the soluble fraction. It was readily purified by one-step heparin–agarose affinity chromatograph. The ability of CH/71 binding cells was about 8-fold of that of Cell I–Hep II domain FN.     

小鼠TAp63γ及两种突变体的原核表达、纯化和DNA结合活性

采用PCR扩增法得到小鼠TAp63γ野生型及两种缺失突变体的cDNA,3种cDNA与表达载体pGEX-2TK重组构建成GST融合表达质粒并转化感受态E.coli BL21 (DE3),经IPTG诱导了小鼠TAp63γ野生型及两种缺失突变体的可溶性表达. 诱导表达的菌液经离心收集菌体、超声破碎及Triton X-100增溶后获得可溶性表达蛋白粗提液. 利用Glutathione Sepharose 4 Fast Flow亲合层析纯化出电泳均一的3种GST融合蛋白. 凝胶滞留分析证实仅野生型小鼠TAp63γ蛋白能特异结合p53靶序列,经序列比对及同源建模分析,表明小鼠TAp63γ DBD结合区的完整性、关键氨基酸的保守性及三维结构的相似性可能是其DNA结合活性所必需的.     

Cloning and expression of a Staphylococcus aureus gene encoding a peptidoglycan hydrolase activity.

A gene of Staphylococcus aureus PS47 encoding lytic activity was cloned and expressed in Escherichia coli. Deletion analysis of a recombinant plasmid carrying a 7.4-kilobase-pair fragment (kbp) of S. aureus DNA suggested that the gene was located within a 2.5-kbp EcoRI-XbaI fragment. Analysis of extracts of E. coli harboring recombinant plasmids on denaturing polyacrylamide gels containing purified cell walls of S. aureus showed a clearing zone by a polypeptide of apparent Mr 23,000. The release of dinitrophenylalanine but not reducing groups from purified cell walls by a cell extract of recombinant E. coli suggested that we had cloned an N-acetylmuramyl-L-alanine amidase.     

Recombinant expression and characterization of a novel fibronectin isoform expressed in cartilaginous tissues

A novel fibronectin (FN) isoform lacking the segment from IIICS (type III connecting segment) through the I-10 module is expressed predominantly in normal cartilaginous tissues. We expressed and purified recombinant cartilage-type FN using a mammalian expression system and characterized its molecular and biological properties. Although FNs have been shown to be secreted as disulfide-bonded dimers, cartilage-type FN was secreted mainly as a monomer. It was less potent than plasma-type FN in promoting cell adhesion and binding to integrin alpha5beta1, although it was more active than plasma-type FN in binding to chondroitin sulfate E. When added exogenously, cartilage-type FN was poorly assembled into the fibrillar FN matrix, mostly because of its monomeric structure. Given that cartilage is characterized by its non-fibrillar matrix with abundant chondroitin sulfate-containing proteoglycans, it is likely that cartilage-type FN has evolved to adapt itself to the non-fibrillar structure of the cartilage matrix through acquisition of a novel mechanism of alternative pre-mRNA splicing.     

垂体腺苷酸环化酶激活肽基因合成表达和产物纯化与鉴定

为利用基因工程技术获得垂体腺苷酸环化酶激活肽 (pituitaryadenylatecyclaseactivatingpolypeptide ,PACAP) ,根据大肠杆菌的密码偏好性 ,设计并人工合成编码 38个氨基酸的PACAP基因 .克隆到表达载体pET 35b(+) ,构建重组质粒pET PACAP ,转化大肠杆菌BL2 1 (DE3)pLysS+ .实现纤维素结合域 (cellulosebindingdomain ,CBD)与PACAP融合蛋白的表达 ,并在两者之间引入 (凝血 )因子Ⅹa识别位点 (Ile Glu Gly Arg↓ ) .融合蛋白CBD PACAP经纤维素亲和层析纯化后 ,因子Ⅹa酶切释放PACAP .在因子Ⅹa识别位点前引入 7个氨基酸的柔性短肽 (Gly Thr Gly Gly Gly Ser Gly)明显提高了融合蛋白对因子Ⅹa的敏感性 .HPLC进一步纯化得到纯度大于 95 %PACAP多肽 .所得的PACAP多肽的Western印迹鉴定为阳性 ;激光飞行质谱测定分子量结果与理论值相符 .生物活性分析表明 ,所制备的PACAP具有促进胰腺癌细胞株SW 1 990胞内cAMP合成的活性     

Mapping the collagen-binding site of human fibronectin by expression in Escherichia coli.

The collagen-binding domain of human fibronectin has been expressed as a cro/beta-galactosidase fusion protein in Escherichia coli. The hybrid polypeptide was recognized by an anti-(human plasma fibronectin) serum and bound specifically to gelatin-Sepharose. The collagen-binding region was subdivided by constructing a series of overlapping bacterial expression plasmids. The fusion proteins produced by these constructs were analysed for gelatin-binding activity. The results indicate that the binding site lies within an approximately 12.5 kd fragment of fibronectin, and show that the following 14 amino acid sequence is critical for gelatin-binding activity: Ala-Ala-His-Glu-Glu-Ile-Cys-Thr-Thr-Asn-Glu-Gly-Val-Met. This sequence links the second type II homology unit with the adjacent type I repeat in the amino-terminal third of the fibronectin molecule.     

Syntheses of recombinant yellowtail and flounder growth hormones in Escherichia coli.

For syntheses of recombinant yellowtail and flounder growth hormones (r-yGH and r-fGH) in E. coli, expression plasmids were constructed. The expression level of r-yGH and r-fGH in the host cells were very high, reaching 15 and 8% of the total protein, respectively. These product proteins were accumulated in inclusion bodies in the cells. The recombinant hormones were isolated from the pellets ina glutathione reduction/oxidation buffer. The refolded hormones were further purified by DEAE-Toyopearl 650M chromatography to homogeneity. The purified r-yGH and r-fGH were composed of 188 and 174 amino acid residues, respectively, having amino-terminal sequences starting with methionine. The recombinant hormones had potent growth-promoting activities on juvenile rainbow trout Salmo gairdneri in a dose-dependent manner.